Strategy Inc. (MSTR)
MicroStrategy bets big with a new $700M debt offering to fuel Bitcoin purchases
MicroStrategy (NASDAQ: MSTR), the largest publicly traded corporate holder of Bitcoin (BTC), has announced an upsized debt offering to fund further cryptocurrency acquisitions.
Why Bernstein Is Betting Big on MicroStrategy (MSTR) Stock
Shares of enterprise software specialist MicroStrategy (NASDAQ: MSTR ) are declining on Friday, capping off what is about to be a down week for MSTR stock. This move is reflective of its evolved role as a cryptocurrency proxy, with the digital asset sector also suffering a rough week.
MicroStrategy increases debt offering by 40% to $700 M to purchase more Bitcoin
American software technology firm MicroStrategy has announced the pricing of a new $700 million debt offering due in 2032. The company plans to use the proceeds from this offering to purchase more Bitcoin, continuing its aggressive strategy to add the cryptocurrency to its corporate treasury.
Analysts update MicroStrategy stock price target
2024 was nothing short of impressive for MicroStrategy (NASDAQ: MSTR) as the largest institutional holder of Bitcoin (BTC) continued with its aggressive acquisition strategy of maiden crypto, as its subsequent rise in value by 51% in the first six months, more than doubled MSTR stock value.
MicroStrategy's stock falls after convertible-debt offering plan
Shares of MicroStrategy Inc. MSTR, +3.10% fell 0.9% in premarket trading Thursday, after the business-analytics and bitcoin play said it planned to offer $500 million in convertible debt. The senior notes, due 2032, would be convertible to cash, MicroStrategy shares or a combination of both.
Wall Street Loves These Crypto Stocks: 7 to Buy Today
With Bitcoin back above $70,000, it's fueling upside for some of the top crypto stocks to buy. That includes MicroStrategy (NASDAQ:MSTR).
The Growth Stock Reckoning: 3 Stocks to Sell Before the Bubble Bursts
The U.S. equities rally, while facing some headwinds this week, appears largely intact. The S&P500 has risen 10.4% since the start of the year, slightly trailing the tech-heavy Nasdaq Composite, which has, in turn, gained 12.5% during the same period.
Up 125% for the Year, Is MicroStrategy Still a Buy?
Due its large holdings of Bitcoin, MicroStrategy continues to attract attention from investors looking for Bitcoin proxy stocks. With the launch of the new spot Bitcoin ETFs this year, however, the Bitcoin proxy stock investment thesis may be losing steam.
Will MicroStrategy Be Next To Issue a Stock Split?
Source: Pinkypills / Getty Images MicroStrategy's Platform Analytics are used by WalMart, Amazon, Apple, and CVS, among others.
MSTY: A Risky Buy Based On An Equally Risky Bearish Bitcoin Outlook
Yieldmax MSTR Option Income Strategy ETF focuses on maximizing investment returns on MicroStrategy Incorporated using an options strategy. The MSTY fund's distributions have been excellent, but it is a new fund with no trends to indicate if returns will persist. MSTY is a suitable option for MicroStrategy investors looking to take advantage of an eventual re-rating on weak fundamentals, but the timing isn't right now, with Bitcoin rallying hard.
Your Portfolio Is a Garden. Weed It
I don't believe in the old stock-market saying “Sell in May and Go Away.” In my opinion, you should never “go away” from the stock market altogether. But May is a good time to weed out your portfolio. Unless you have a strong reason to do otherwise, I would: Here are a few large, widely held stocks that I would consider selling now. MicroStrategy Inc. (MSTR, Financial), a Tysons Corner, Virginia company headed by Michael Saylor, sells software for enterprise analytics and mobility. But the stock doesn't trade based on that business. It trades based on the company's holdings of bitcoin. MicroStrategy owns some 214,000 of the crypto tokens. That is more than 1% of the 19.7 million bitcoins that have been issued so far. It's about 1% of the 21 million coins that will ultimately be issued. As of May 19, one bitcoin cost $66,934.60. So 214,000 of them would be valued at $14.3 billion. That is about half the market value of MicroStrategy stock. MicroStrategy has financed its cryptocurrency purchases in large part by issuing notes convertible to common stock. So the current stockholders are at risk of seeing the value of their holdings diluted. The company has posted a loss in three of the past four years. Carlyle Group Inc. (CG, Financial), with headquarters in Washington D.C., is one of the larger private equity firms in the U.S. Such firms invest in private companies or take public companies private. They often cut costs, try to enhance revenue and then take the companies public in a few years. The acquisitions are usually done with borrowed money, and the cost of borrowing money has risen a lot in the past year. The stock seems expensive to me at 12 times the company's revenue. Revenue has declined over the past year, five years and 10 years. Muscular diseases are the focus at Cytokinetics Inc. (CYTK, Financial), a biotechnology firm based in South San Francisco, California. It is working on treatments for amyotrophic lateral sclerosis (Lou Gehrig's disease), heart failure and several other conditions. The company has posted losses in 13 of the past 15 years. Its liabilities currently exceed its assets by about $396 million. A clinical research breakthrough could prove me wrong, but I think the stock is overvalued at the current market capitalization of of $6.2 billion. In the past few years, Boeing Co. (BA, Financial) planes have experienced two controversial crashes and one notorious door-panel blowout. The company will have to spend more on safety and redundant quality checks. This will slow down production and dampen sales, I believe. Boeing has liabilities of $151.5 billion and assets of $134.50 billion. Of the past 10 years, only five have been profitable. Lyft Inc. (LYFT, Financial) plays second fiddle to Uber Technologies Inc. (UBER, Financial) in the U.S. ride-hailing market, with $4.4 billion in revenue last year, compared to Uber's $37.3 billion. While Uber turned profitable in 2023, Lyft has yet to show an annual profit, although analysts expect to see one this year. To me it is a cautionary sign that Lyft's debt is more than twice the company's equity. I offer sell recommendations once a year in this column, usually in May. My “sells” from a year ago trailed the Standard & Poor's 500 Total Return Index by 10 percentage points, rising 18.40% while the index climbed 28.42%. Clorox Co. (CLX, Financial) declined 14%. Colgate-Palmolive Co. (CL, Financial) and Keurig Dr. Pepper Inc. (KDP, Financial) rose, but less than the benchmark. International Business Machines Corp. (IBM, Financial) and Salesforce Inc. (CRM, Financial) beat the index, with gains of 38% and 36% respectively. Longer-term results are mixed. My sell recommendations have trailed behind the index 10 times out of 16 – as they should. However, due to bad picks I made in 2005 and 2010, the average return on my sells has been 13%, while the S&P has averaged 12.20%. Bear in mind that my column results are hypothetical and shouldn't be confused with results I obtain for clients. Also, past performance doesn't predict the future. Disclosure: A hedge fun I manage owns put options on Boeing. John Dorfman is chairman of Dorfman Value Investments LLC in Boston, Massachusetts, and a syndicated columnist. His firm or clients may own or trade securities discussed in this column. He can be reached at [email protected].
MSTR Outlook: One Weird (but Smart) Reason to Buy MicroStrategy Stock Now
MicroStrategy (NASDAQ: MSTR ) Chairman Michael Saylor is a famous Bitcoin ( BTC-USD ) bull. You don't have to be famous, but you'll definitely need to be a Bitcoin believer if you intend to buy and hold MicroStrategy stock.
